Nutritional Status and Nutritional Support Before and After Pancreatectomy for Pancreatic Cancer and Chronic Pancreatitis

被引:40
作者
Vasiliki Th. Karagianni
Apostolos E. Papalois
John K. Triantafillidis
机构
[1] Department of Gastroenterology Center for Inflammatory Bowel Disease, Saint Panteleimon General Hospital, 18454 Nikaia, Athens
[2] Experimental-Research Center, ELPEN Pharmaceuticals, 19009 Pikermi, Athens
[3] Haidari, 12461
关键词
Chronic pancreatitis; Nutritional status; Nutritional support; Pancreatectomy; Pancreatic cancer;
D O I
10.1007/s13193-012-0189-4
中图分类号
学科分类号
摘要
Cachexia, malnutrition, significant weight loss, and reduction in food intake due to anorexia represent the most important pathophysiological consequences of pancreatic cancer. Pathophysiological consequences result also from pancreatectomy, the type and severity of which differ significantly and depend on the type of the operation performed. Nutritional intervention, either parenteral or enteral, needs to be seen as a method of support in pancreatic cancer patients aiming at the maintenance of the nutritional and functional status and the prevention or attenuation of cachexia. Oral nutrition could reduce complications while restoring quality of life. Enteral nutrition in the post-operative period could also reduce infective complications. The evidence for immune-enhanced feed in patients undergoing pancreaticoduodenectomy for pancreatic cancer is supported by the available clinical data. Nutritional support during the post-operative period on a cyclical basis is preferred because it is associated with low incidence of gastric stasis. Postoperative total parenteral nutrition is indicated only to those patients who are unable to be fed orally or enterally. Thus nutritional deficiency is a relatively widesoread and constant finding suggesting that we must optimise the nutritional status both before and after surgery. © 2012 Indian Association of Surgical Oncology.
引用
收藏
页码:348 / 359
页数:11
相关论文
共 70 条
  • [1] Rocha-Lima C.M., New directions in the management of advanced pancreatic cancer: a review, Anticancer Drugs, 19, pp. 435-446, (2008)
  • [2] Bozzetti F., Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients, Support Care Cancer, 17, pp. 279-284, (2009)
  • [3] Ockenga J., Valentini L., Review article: anorexia and cachexia in gastrointestinal cancer, Aliment Pharmacol Ther, 22, pp. 583-594, (2005)
  • [4] Uomo G., Gallucci F., Rabitti P.G., Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management, Jop, 7, pp. 157-162, (2006)
  • [5] Di Luzio R., Moscatiello S., Marchesini G., Role of nutrition in gastrointestinal oncological patients, Eur Rev Med Pharmacol Sci, 14, pp. 277-284, (2010)
  • [6] Bachmann J., Heiligensetzer M., Krakowski-Roosen H., Buchler M.W., Friess H., Martignoni M.E., Cachexia worsens prognosis in patients with resectable pancreatic cancer, J Gastrointest Surg, 12, pp. 1193-1201, (2008)
  • [7] Bachmann J., Ketterer K., Marsch C., Fechtner K., Krakowski-Roosen H., Buchler M.W., Friess H., Martignoni M.E., Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function, BMC Cancer, 9, (2009)
  • [8] Raghu Dhanapal R., Saraswathi T.R., Rajkumar N., Govind R.N., Cancer cachexia, J Oral Maxillofac Pathol, 15, pp. 257-260, (2011)
  • [9] Ramos E.J., Suzuki S., Marks D., Inui A., Asakawa A., Meguid M.M., Cancer anorexia-cachexia syndrome: cytokines and neuropeptides, Curr Opin Clin Nutr Metab Care, 7, pp. 427-434, (2004)
  • [10] Legakis I., Stathopoulos J., Matzouridis T., Stathopoulos G.P., Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals, Anticancer Res, 29, pp. 3949-3952, (2009)